Finasteride for Women: Is It Safe, and Does It Work for Female Hair Loss?
Finasteride is not FDA-approved for women and must not be used in pregnancy because it can harm a male fetus. At 1 mg a day it did no better than placebo in postmenopausal women; small uncontrolled studies at higher doses look better, and dermatologists may prescribe it off-label to women who cannot become pregnant.
By Kymata Health Editorial Published Last checked
This guide
Women's Hair Loss- Question
- Is finasteride safe for women with hair loss, and does it work?
- Sources
- 8 cited
- Quick answers
- 3 questions
- Clinician review
- None; sources cited inline
Key takeaways
5 points- Finasteride 1 mg (Propecia) is approved for male pattern hair loss in men only; its label says it is not indicated for women and is contraindicated in pregnancy1.
- Because of the risk to a male fetus, the label says women who are or may be pregnant should not handle crushed or broken tablets1.
- In a year-long, Merck-supported trial of 137 postmenopausal women, finasteride 1 mg a day did not increase hair growth or slow thinning compared with placebo2.
- Reports of benefit in female pattern hair loss come mostly from studies without a placebo group, some at 5 mg a day45.
- No topical finasteride is FDA-approved, and the FDA has warned about compounded topical versions, including the risk of transfer to women6.
Not approved for women, and never in pregnancy
Finasteride 1 mg (Propecia) is FDA-approved for male pattern hair loss in men only. Its label says it is not indicated for use in women and lists pregnancy as a contraindication1.
Finasteride lowers DHT by blocking the conversion of testosterone2. Because of that, the label says it may cause abnormalities of the external genitalia of a male fetus, as low doses did in pregnant rats, and women who are pregnant or may become pregnant should not handle crushed or broken tablets; the coating on whole tablets prevents contact during normal handling1.
The AAD says a dermatologist may prescribe finasteride to a woman who has hereditary hair loss and cannot get pregnant7. A 2026 review lists finasteride and dutasteride among off-label options for female pattern hair loss8.
Does it work for female hair loss?
The largest placebo-controlled trial enrolled 137 postmenopausal women aged 41 to 60 and gave finasteride 1 mg a day or placebo for a year. Hair counts, photos, patient and investigator ratings and scalp biopsies all showed no benefit, and both groups lost hair at the front and middle of the scalp. The trial was supported by Merck Research Laboratories2.
A Cochrane review pooled three trials of finasteride 1 mg vs placebo in women: 30 of 67 improved on finasteride and 33 of 70 on placebo, and it concluded finasteride was no more effective than placebo, on low-quality evidence3.
A 2019 systematic review found 65 studies of finasteride in 2,683 females aged 6 to 88, at doses of 0.5 to 5 mg a day. Its randomized trials mainly supported finasteride for hirsutism, while reports of improvement in female pattern hair loss came from other prospective and retrospective studies4.
In one such study, 40 postmenopausal women with normal androgen levels took 5 mg a day for 18 months with no comparison group. At 6 months, 22 rated themselves significantly improved, 12 moderately and 6 not at all; older women tended to respond less5.
Topical finasteride is not FDA-approved
There is no FDA-approved topical finasteride. In April 2025 the FDA warned about compounded topical products sold by compounders and telemedicine platforms, citing 32 adverse-event reports from 2019 to 2024, including anxiety, depression, suicidal ideation, brain fog and decreased libido; most reports said the problems persisted after stopping6.
Finasteride is absorbed through the skin, and topical products lack the tablet coating, so the FDA flagged a greater risk of accidental exposure to others, specifically females, through transfer of applied product6.
Side effects, and who should avoid it
Most safety data come from men. The Propecia label lists decreased libido, erectile dysfunction and ejaculation disorder as the most common side effects, and postmarketing reports include depression and suicidal ideation and behavior1. In the 5 mg study in women, four of 40 reported a lasting drop in libido and one had raised liver enzymes5; in the 1 mg trial, finasteride was generally well tolerated2.
- Avoid it if you are pregnant, could become pregnant or are trying to conceive: finasteride is contraindicated in pregnancy1.
- Raise any history of depression with your prescriber first; depression and suicidal ideation are among the postmarketing reports on the label1.
- Ask about the risks before using compounded topical finasteride; the FDA recommends consumers consult health care providers and compounders first6.
- See a dermatologist to confirm the type of hair loss; the AAD says the medicine chosen depends on the cause, your overall health, age and plans for getting pregnant7.
What to consider instead
Topical minoxidil is the only FDA-approved treatment for female pattern hair loss8, and in the Cochrane review it roughly doubled the chance of moderate to marked regrowth vs placebo3. See our minoxidil guide.
Spironolactone is another off-label pill option8. The AAD warns it can cause birth defects, so women who could become pregnant are prescribed birth control with it7. See our spironolactone guide, and our PRP guide for the in-office option.
Quick answers
Questions
3 answersCan women take finasteride for hair loss?
Only off-label, and only when pregnancy is not possible. The label says it is not indicated for women and is contraindicated in pregnancy1; the AAD says dermatologists may prescribe it to women with hereditary hair loss who cannot get pregnant7.
Is topical finasteride safer?
That has not been shown. No topical finasteride is FDA-approved, it is absorbed through the skin, and the FDA has received reports of persistent side effects with compounded versions6.
More in Women's Hair Loss
Keep reading
6 pages- Women's Hair Loss hubEvery guide, regulatory notes and sources
- Minoxidil for Women: Topical Foam vs Low-Dose Pills, by the Trials
- Spironolactone for Female Pattern Hair Loss: What the Evidence Shows
- Hair Loss Supplements for Women: Biotin, Nutrafol and What the Trials Show
- Telogen Effluvium: How Long Does Stress or Postpartum Hair Shedding Last?
- PRP for Hair Loss in Women: Does It Work, How Many Sessions, and Who Should Skip It
Keep reading: Menopause and HRT
Menopause and HRT: every pageWomen's hormone telehealth comparedBrowse all topics
- Previous in this topicPRP for Hair Loss in Women: Does It Work, How Many Sessions, and Who Should Skip ItPooled trials suggest platelet-rich plasma (PRP) injections can raise hair density in women, but the evidence is low quality, protocols vary, and a well-known US trial found no…
- Next in this topicWomen's Hair Loss: Minoxidil, Spironolactone, Laser Caps and Supplements, by the EvidenceTopical minoxidil has the best evidence for female pattern hair loss, and low-dose oral minoxidil matched it in a pooled analysis of trials.
- PCOS (Now PMOS) and Irregular Cycles: Diagnosis, Treatment and Supplements, by the EvidencePCOS was renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026, but how it is diagnosed has not changed.
- Zinc Picolinate, Citrate or Gluconate? The Absorption Data, and Why More Zinc Can Cost You CopperZinc labels compete on form and milligrams.
- Minoxidil: Topical vs Oral, for Men and Women, by the Trials and the LabelsMinoxidil foam and solution are sold over the counter to regrow scalp hair in men and women.
References
Every study and document cited in this guide, numbered as in the text.
Sources
8 sources- 1PROPECIA (finasteride) tablets: prescribing information (revised 07/2022). U.S. Food and Drug Administration, 2022.
- 2Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol, 2000. PMID 11050579
- 3Interventions for female pattern hair loss. Cochrane Database Syst Rev, 2016. PMID 27225981
- 4The efficacy and use of finasteride in women: a systematic review. Int J Dermatol, 2019. PMID 30604525
- 5Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women. Int J Trichology, 2013. PMID 23960392
- 6FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products. U.S. Food and Drug Administration, 2025.
- 7Hair loss: Diagnosis and treatment. American Academy of Dermatology, 2022.
- 8Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. Am J Clin Dermatol, 2026. PMID 41714473
Dietary supplements are not intended to diagnose, treat, cure or prevent any disease, and these statements have not been evaluated by the FDA. Prescription options need a licensed clinician. Talk to your clinician or pharmacist before starting anything new, especially if you take prescription medicines, are pregnant or breastfeeding.